Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Fluxes through intrahepatic glucose-producing metabolic pathways were measured in normal humans during overnight or prolonged (60 h) fasting. The glucuronate probe was used to measure the turnover and sources of hepatic UDP-glucose; mass isotopomer distribution analysis from [2-13C1]glycerol for gluconeogenesis and UDP-gluconeogenesis; [U-13C6]glucose for glucose production (GP) and the direct UDP-glucose pathway; and [1-2H1]galactose for UDP-glucose flux and retention in hepatic glycogen. After overnight fasting, GP (fluxes in milligram per kilogram per minute) was 2.19+/-0.09, of which 0.79 (36%) was from gluconeogenesis, 1.40 was from glycogenolysis, 0.30 was retained in glycogen via UDP-gluconeogenesis, and 0.17 entered hepatic UDP-glucose by the direct pathway. Thus, total flux through the gluconeogenic pathway (1.09) represented 54% of extrahepatic glucose disposal (2.02) and the net hepatic glycogen depletion rate was 0.93 (46%). Prolonging [2-13C1]glycerol infusion slowly increased measured fractional gluconeogenesis. In response to prolonged fasting, GP was lower (1. 43+/-0.06) and fractional and absolute gluconeogenesis were higher (78+/-2% and 1.11+/-0.07, respectively). The small but nonzero glycogen input to plasma glucose (0.32+/-0.03) was completely balanced by retained UDP-gluconeogenesis (0.31+/-0.02). Total gluconeogenic pathway flux therefore accounted for 99+/-2% of GP, but with a glycogen cycle interposed. Prolonging isotope infusion to 10 h increased measured fractional gluconeogenesis and UDP-gluconeogenesis to 84-96%, implying replacement of glycogen by gluconeogenic-labeled glucose. Moreover, after glucagon administration, GP (1.65), recovery of [1-2H1]galactose label in plasma glucose (25%) and fractional gluconeogenesis (91%) increased, such that 78% (0.45/0.59) of glycogen released was labeled (i.e., of recent gluconeogenic origin). In conclusion, hepatic gluconeogenic flux into glycogen and glycogen turnover persist during fasting in humans, reconciling inconsistencies in the literature and interposing another locus of control in the normal pathway of GP.

[1]  K. Marsh,et al.  Glucose homeostasis in children with falciparum malaria: precursor supply limits gluconeogenesis and glucose production. , 1997, The Journal of clinical endocrinology and metabolism.

[2]  S. Turner,et al.  Altered fluxes responsible for reduced hepatic glucose production and gluconeogenesis by exogenous glucose in rats. , 1997, The American journal of physiology.

[3]  S. Turner,et al.  Measurement of hepatic Ra UDP-glucose in vivo in rats: relation to glycogen deposition and labeling patterns. , 1997, The American journal of physiology.

[4]  J. Wahren,et al.  Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.

[5]  G. Lopaschuk,et al.  Contribution of glycogen to aerobic myocardial glucose utilization. , 1996, Circulation.

[6]  M. Hellerstein.  Isotopic studies of carbohydrate metabolism in non-insulin-dependent diabetes mellitus , 1995 .

[7]  S. Turner,et al.  Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. , 1995, The Journal of clinical investigation.

[8]  M. Stumvoll,et al.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. , 1995, The Journal of clinical investigation.

[9]  K. Rother,et al.  Hepatic glycogen accurately reflected by acetaminophen glucuronide in dogs refed after fasting. , 1995, The American journal of physiology.

[10]  K. Rother,et al.  Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen. , 1995, The American journal of physiology.

[11]  J. Wahren,et al.  Gluconeogenesis and Glucuronidation in Liver in Vivo and the Heterogeneity of Hepatocyte Function (*) , 1995, The Journal of Biological Chemistry.

[12]  V. Large,et al.  Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose. , 1995, The American journal of physiology.

[13]  H. Brunengraber,et al.  Limitations of the Mass Isotopomer Distribution Analysis of Glucose to Study Gluconeogenesis , 1995, The Journal of Biological Chemistry.

[14]  M. Hellerstein,et al.  Gluconeogenesis and Intrahepatic Triose Phosphate Flux in Response to Fasting or Substrate Loads. APPLICATION OF THE MASS ISOTOPOMER DISTRIBUTION ANALYSIS TECHNIQUE WITH TESTING OF ASSUMPTIONS AND POTENTIAL PROBLEMS (*) , 1995, The Journal of Biological Chemistry.

[15]  M. Hellerstein,et al.  Rate of glucose entry into hepatic uridine diphosphoglucose by the direct pathway in fasted and fed states in normal humans. , 1995, Metabolism: clinical and experimental.

[16]  D L Rothman,et al.  Contribution of Hepatic Glycogenolysis to Glucose Production in Humans in Response to a Physiological Increase in Plasma Glucagon Concentration , 1995, Diabetes.

[17]  M. Hellerstein,et al.  CALCULATIONS FOR GLUCONEOGENESIS BY MASS ISOTOPOMER DISTRIBUTION ANALYSIS , 1995 .

[18]  M. Stumvoll,et al.  Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. , 1995, The Journal of clinical investigation.

[19]  J. Wahren,et al.  Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. , 1995, The Journal of clinical investigation.

[20]  R. Shulman,et al.  Liver glycogen turnover in fed and fasted humans. , 1994, The American journal of physiology.

[21]  R. DeFronzo,et al.  Glycogen turnover during refeeding in the postabsorptive dog: implications for the estimation of glycogen formation using tracer methods. , 1994, Metabolism: clinical and experimental.

[22]  J. Clore,et al.  Suppression of Gluconeogenesis After a 3-Day Fast Does Not Deplete Liver Glycogen in Patients With NIDDM , 1994, Diabetes.

[23]  E. Barrett,et al.  Hepatic glucose metabolism and insulin resistance in NIDDM and obesity. , 1993, Bailliere's clinical endocrinology and metabolism.

[24]  N. Barzilai,et al.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. , 1993, The Journal of clinical investigation.

[25]  M. Hellerstein,et al.  Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. , 1992, The American journal of physiology.

[26]  R G Shulman,et al.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. , 1991, Science.

[27]  J. Wahren,et al.  Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. , 1991, The Journal of biological chemistry.

[28]  G. Shulman,et al.  Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. , 1990, The American journal of physiology.

[29]  T. Jenssen,et al.  Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. , 1990, The Journal of clinical investigation.

[30]  R. Wolfe,et al.  The relationship between gluconeogenic substrate supply and glucose production in humans. , 1990, The American journal of physiology.

[31]  A. Consoli,et al.  Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. , 1987, The Journal of clinical investigation.

[32]  D. Greenblatt,et al.  Glycoconjugates as noninvasive probes of intrahepatic metabolism: pathways of glucose entry into compartmentalized hepatic UDP-glucose pools during glycogen accumulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Lange,et al.  Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. , 1980, The Journal of biological chemistry.

[34]  B. Ross,et al.  Paracetamol metabolism by the isolated perfused rat kidney. , 1980, Kidney international.

[35]  M. Ui,et al.  Glucose load diverts hepatic gluconeogenic product from glucose to glycogen in vivo. , 1978, The American journal of physiology.

[36]  G Levy,et al.  Pharmacokinetics of acetaminophen elimination by anephric patients. , 1976, The Journal of pharmacology and experimental therapeutics.

[37]  H G Hers,et al.  The control of glycogen metabolism in the liver. , 1976, Annual review of biochemistry.

[38]  E. Hultman,et al.  Carbohydrate metabolism of the liver in normal man under varying dietary conditions. , 1973, Scandinavian journal of clinical and laboratory investigation.

[39]  A. Lehninger.  Biochemistry: The Molecular Basis of Cell Structure and Function , 1970 .

[40]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[41]  E H STRISOWER,et al.  Conversion of fatty acids to carbohydrate; application of isotopes to this problem and role of the Krebs cycle as a synthetic pathway. , 1957, Physiological reviews.